On March 4, 2025, PurposeMed announced the successful completion of its growth financing round led by True North Fund, with major participation by BDC and Panache Ventures.
PurposeMed is a Calgary-based, high-growth digital health company that provides accessible and specialized healthcare services, focusing on underserved populations across Canada and the United States. They were recently ranked Canada’s second-fastest-growing technology company and seventh in North America by Deloitte.
Osler, Hoskin & Harcourt LLP advised PurposeMed with a team consisting of Mark Longo, Michael Grantmyre, Ian Nelson, JD D’Souza (Emerging and High Growth Companies) and Gaby Fekete (articling student).
Key Contact
Vancouver Managing Partner, Vancouver
Team
Partner, Emerging and High Growth Companies, Calgary
Associate, Emerging and High Growth Companies, Vancouver
Associate, Emerging and High Growth Companies, Calgary
Articling Student, Calgary